HCPCS Code J3241: Injection, Teprotumumab-trbw, 10 mg

In general, even if medicines have undergone numerous clinical trials, it's important to know that they will still have risks even after being approved. For this medicine in particular, common risks include pain in the IV site, headaches, and muscle spasms. The worst reactions include allergic reactions and hyperglycemia (which is why we mentioned earlier that you have to monitor and manage the blood sugar levels of the patient). It's also possible for them to have hearing problems.

No. It's important for patients to get this injection over the course of multiple sessions. The benefits will only start showing after a few repeat visits.

They can take oral corticosteroids instead. They can also opt for orbital radiotherapy or orbital decompression surgery.